PSY36 Economic Evaluation of Pegvisomant for Active Acromegaly Patients Who Failed Available Therapies in Brazil – Public Health Care System Perspective
Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.570
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2012
Authors
Publisher
Elsevier BV